204例住院患者精神药物一日处方分析

中国药物警戒 ›› 2017, Vol. 14 ›› Issue (1): 45-48.

204例住院患者精神药物一日处方分析

刘昀, 陈金兰

广州市民政局精神病院,广东广州 510430

收稿日期:2017-02-16 修回日期:2017-02-16 出版日期:2017-01-20 发布日期:2017-02-16
作者简介:刘昀,女,硕士,副主任药师,医院药学。

Daily Prescription Analysis of Psychotropic Drugs of 204 Inpatients

LIU Yun, CHEN Jin-lan

Guangzhou Bureau of Civil Affairs Psychiatric Hospital, Guangdong Guangzhou 510430, China

Received:2017-02-16 Revised:2017-02-16 Online:2017-01-20 Published:2017-02-16
Contact: 陈金兰,女,本科,主任药师,医院药学。E-mail：1354957802@qq.com

摘要/Abstract

摘要： 目的了解本院安康管治所住院患者精神药物临床使用情况。方法使用一日法对住院患者的精神药物处方进行分析。结果新型抗精神病药物占据主导地位,利培酮使用比例最高;苯二氮?仍然作为常用的抗焦虑和镇静催眠药物;丙戊酸盐使用率偏高,应警惕不良反应;精神药物的使用剂量基本都在推荐的安全剂量之内;两药联用87例（占42.65%）多于单药治疗60例（占29.41%）,治疗方案大多数合理。结论目前本院安康管治所精神药物使用基本合理。

关键词: 住院患者, 精神药物, 处方, 分析

Abstract: ObjectiveTo investigate the use of psychotropic drugs of detention inpatients in our hospital. MethodsOne-day prescriptions of psychotropic drugs for detention inpatients in our hospital were analyzed. ResultsSecond-generation antipsychotics were predominant psychotropic drugs, and the most widely used agent is risperidone. Benzodiazepines were regularly used as anxiolytics-hypnotics. The usage rate of valproic acid was relatively high and associate adverse reactions should be alerted. Dosages of psychotropic drugs were on the recommended therapeutic ranges generally. The percentage of prescriptions consisting of two drugs (42.65%) was higher than prescriptions of monotherapy (29.41%), and regimens were reasonable for most cases. ConclusionCurrently, the use of psychotropic drugs for detention inpatients in our hospital is generally reasonable.

Key words: inpatient, psychotropic drug, prescription, analysis

中图分类号:

R969.3

刘昀, 陈金兰. 204例住院患者精神药物一日处方分析[J]. 中国药物警戒, 2017, 14(1): 45-48.

LIU Yun, CHEN Jin-lan. Daily Prescription Analysis of Psychotropic Drugs of 204 Inpatients[J]. Chinese Journal of Pharmacovigilance, 2017, 14(1): 45-48.

参考文献

[1] 世界卫生组织.ICD-10精神与行为障碍分类.临床描述与诊断要点[M].北京:人民卫生出版社,1993：72-106, 177-182.
[2] 王来海,吕路线.临床精神药物学[M].北京:人民卫生出版社,2009: 2-12.
[3] 张云淑,司天梅,粟克清.中国十省市第一代及第二代抗精神病药使用现况调查[J].中国心理卫生杂志, 2012, 26(10): 736-740.
[4] Kuroki T, Nagao N, Nakahara T.Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis[J].Prog Brain Res, 2008,172(5):199-212.
[5] Moller H J, Riedel M, Jager M, et al. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia:8-week resuli of a randomized controlled trial within the German Research Network on Schizophrenia[J].Int J Neuropsychopharmaol,2008, 11(7): 985-997.
[6] Gareri P, De Fazio P, Stilo M, et al. Conventional and Atypical Antipsychotics in the Elderly:A Review[J].Clin Drug Investig,2003, 23(5):287-322.
[7] Perez V, Canas F, Tafalla M, et al. A 12-month, openlabel, comparative study of quetiapine and risperidone in the acute long-term treatment of schizophrenia[J].Int Clin Psychopharmacol,2008,23(3):138-149.
[8] Addington D E, Pantelis C, Dineen M, et al. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double- blind,multicenter trial[J].J Clin Psychiatry,2004,65(12):1624-1633.
[9] Zhong K X, Sweitzer D E, Hamer R M, et al.Comparison of quetiapine and risperidone in the treatment of schizophrenia:A randomized, double-blind, flexible-dose, 8-week study[J]. J Clin Psychiatry,2006, 67(7):1093-1103.
[10] 戎笛声,位照国,包刚.奥氮平、利培酮、喹硫平、氯丙嗪治疗精神分裂症的早期疗效比较[J].中国现代医生,2010, 48(11):19-20,36.
[11] 杨其兴.奥氮平与利培酮治疗精神分裂症的疗效比较[J].齐齐哈尔医学院学报. 2013, 34(24):3622-3623.
[12] 韩萍,周东升,沃联群.常用非典型抗精神病药物治疗精神分裂症的药物经济学分析[J].中国现代医生,2011,49(31):118-120.
[13] 胡健,施冬青,杜宇锋.住院精神障碍患者抗精神病药物一日处方调查[J].神经疾病与精神卫生, 2011, 11(2):179-181.
[14] 曹延筠.我院精神病住院患者镇静催眠药应用的时点调查分析[J].中国执业药师, 2012, 9(4):7-9.
[15] 李志榕,黄平.劳拉西泮与多虑平治疗焦虑症临床疗效比较[J].临床心身疾病杂志, 2004, 10(1):5-6.
[16] 梁志文.丁螺环酮与劳拉西泮治疗焦虑症的临床分析[J].临床和实验医学杂志, 2009, 8(10):84.
[17] 柴艳丽,杨桂芬,朱文佳.坦度螺酮、文拉法辛和劳拉西泮治疗广泛性焦虑症的疗效比较 [J].中国伤残医学, 2014, 22(4):35-37.
[18] 沈渔邨.精神病学[M].北京:人民卫生出版社, 2007:27, 429.[19] 周赟,陶领钢.丙戊酸盐在精神科应用的研究进展[J].现代中西医结合杂志, 2009, 18(24):2994-2995.
[20] 陈庆强,梁炯河,黄务玲.慢性精神科589例住院患者精神药物处方调查[J]. 2012, 22(7):426-428.
[21] 李晓波,韦伟香.氯氮平联合利培酮治疗难治性精神分裂症的疗效[J].南昌大学学报(医学版）, 2014, 54(3):46-48.
[22] 姜涛,张艳芳,迟勇,等.氯氮平联合齐拉西酮治疗难治性精神分裂症的疗效分析[J].中国医师进修杂志, 2011, 34(34):62-64.
[23] 闻荣海,刘史.氯氮平添加齐拉西酮或喹硫平治疗难治性精神分裂症的对比研究[J].中国民康医学,2015, 27(2):4-6.
[24] 侯春兰,侯凌峰,张东升,等.利培酮口服液合并劳拉西泮治疗躁狂发作兴奋状态的对照研究[J].中国健康心理学杂志,2011, 19(8):913-914.
[25] 陈青松,周蕊,李彦辉,等.利培酮合并丙戊酸镁治疗精神分裂症阴性症状的研究[J].中国保健营养,2013,23(7):3519-3520.
[26] 吴永辉,许维森.联用西酞普兰治疗精神分裂症阴性症状疗效分析[J].临床精神医学杂志, 2009, 19(1):46-47.
[27] 喻东山.抗精神病药的联合应用—读者来信[J].临床精神医学杂志,2011, 21(4):287-288.
[28] 孙树森,赵志刚.临床药师与药物中毒：镇静催眠和抗精神病药物[J].药品评价, 2016, 13(2):8-16.